← NovoCure Ltd NVCR
Market Price
$16.93
Market Cap
$2.01B
P/E Ratio
N/A
Revenue (FY 2025)
↑8.3% YoY
$655.35M
3-Yr CAGR: 6.8%
Net Income
↑19.2% YoY
-$136.23M
Net Margin: -20.8%
Free Cash Flow
↓-9.3% YoY
-$75.68M
FCF Yield: -3.76%
EPS (Diluted)
↑21.8% YoY
$-1.22
Basic: $-1.22
Return on Equity
Efficiency
-40.0%
ROA: -21.1%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (NVCR)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2016 | $82.9M | — | $36.6M | $-131.8M | — | — | — | $-107.6M | $-113.3M | — |
| FY 2017 | $177.0M | +113.6% | $121.4M | $-61.7M | +53.2% | — | — | $-33.1M | $-35.6M | +68.6% |
| FY 2018 | $248.1M | +40.1% | $168.0M | $-63.6M | -3.1% | — | — | $-1.9M | $-4.8M | +86.6% |
| FY 2019 | $351.3M | +41.6% | $262.7M | $-7.2M | +88.6% | — | — | $26.6M | $16.1M | +437.5% |
| FY 2020 | $494.4M | +40.7% | $387.9M | $19.8M | +374.0% | $0.18 | — | $99.1M | $84.2M | +421.7% |
| FY 2021 | $535.0M | +8.2% | $420.2M | $-58.4M | -394.6% | $-0.56 | -411.1% | $82.8M | $58.6M | -30.4% |
| FY 2022 | $537.8M | +0.5% | $423.0M | $-92.5M | -58.6% | $-0.88 | -57.1% | $30.8M | $9.4M | -83.9% |
| FY 2023 | $509.3M | -5.3% | $381.1M | $-207.0M | -123.7% | $-1.95 | -121.6% | $-73.3M | $-100.4M | -1,165.0% |
| FY 2024 | $605.2M | +18.8% | $468.0M | $-168.6M | +18.6% | $-1.56 | +20.0% | $-26.4M | $-69.2M | +31.1% |
| FY 2025 | $655.4M | +8.3% | $488.5M | $-136.2M | +19.2% | $-1.22 | +21.8% | $-49.0M | $-75.7M | -9.3% |
Valuation
Market Price
$16.93
Market Cap
$2.01B
Enterprise Value
$2.11B
P/E Ratio
N/A
P/B Ratio
5.76
FCF Yield
-3.76%
Dividend Yield
N/A
Shares Outstanding
Profitability & Margins
Gross Margin
74.54%
Operating Margin
-23.47%
Net Margin
-20.79%
Return on Equity (ROE)
-40.01%
Return on Assets (ROA)
-21.06%
Asset Turnover
1.01x
Revenue 3-Yr CAGR
6.81%
Financial Health & Liquidity
Current Ratio
2.90
Cash Ratio
0.42
Debt / Equity
0.573
Debt / Assets
0.302
Cash & Equivalents
$93.55M
Total Debt
$195.05M
Book Value / Share
$2.94
Cash Flow Efficiency
Operating Cash Flow
-$49.03M
Capital Expenditures (CapEx)
$26.65M
Free Cash Flow
-$75.68M
OCF / Revenue
-7.48%
FCF / Revenue
-11.55%
FCF 3-Yr CAGR
N/A
Per Share Metrics
EPS (Diluted)
$-1.22
EPS (Basic)
$-1.22
Dividends / Share
N/A
Book Value / Share
$2.94
EPS YoY Growth
21.79%
Balance Sheet (FY 2025)
Total Assets
$646.73M
Total Liabilities
$223.23M
Stockholders' Equity
$340.47M
Current Assets
$646.73M
Current Liabilities
$223.23M